FAQ

renzapride

Known as: 4-amino-5-chloro-2-methoxy-N-(1-azabicyclo-(3.3.1)-non-4-yl)benzamide, Benzamide, 4-amino-N-1-azabicyclo(3.3.1)non-4-yl-5-chloro-2-methoxy-, monohydrochloride, endo-(+-)- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2014
05101519902014

Related topics

Related topics

4 relations

Narrower (1)

BRL 24924

Broader (3)

BenzamidesBridged Bicyclo Compounds, HeterocyclicSerotonin Antagonists

Related mentions per year

Related mentions per year

1954-2018
1960198020002020
renzapride
Serotonin Antagonists
Benzamides
BRL 24924
Bridged Bicyclo Compounds, Heterocyclic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The cardiovascular safety profile of renzapride, a novel treatment for irritable bowel syndrome.
The cardiac safety of renzapride, a novel benzamide currently under clinical development for the treatment of irritable bowel… (More)
Is this relevant?
2006
2006
Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome.
AIM To investigate the efficacy and safety of renzapride, a potent 5-hydroxytryptamine type-4 receptor full agonist and 5… (More)
Is this relevant?
2004
2004
Effect of renzapride on transit in constipation-predominant irritable bowel syndrome.
BACKGROUND & AIMS The aim of this study was to evaluate the dose-ranging pharmacodynamic effects of renzapride, a 5… (More)
Is this relevant?
1998
1998
Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus.
We report here the molecular cloning of three new splice variants of the human serotonin 5-hydroxytryptamine4 (h5-HT4) receptor… (More)
Is this relevant?
1997
1997
Effect of cisapride and renzapride on gastrointestinal motility and plasma motilin concentration in dogs.
The effects of cisapride and renzapride (BRL 24924), on plasma concentration of motilin and gastroduodenal motility were studied… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
1995
1995
Benzimidazolones and renzapride facilitate acetylcholine release from guinea-pig myenteric plexus via 5-HT4 receptors
The effects of the 5-HT4 receptor agonists BIMU 8, BIMU 1, renzapride and of the 5-HT1p receptor agonist 5-hydroxyindalpine on… (More)
  • figure I
  • figure 3
  • figure 2
  • table 1
  • table 2
Is this relevant?
1994
1994
5-HT1A and 5-HT4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons.
The actions of 5-hydroxtryptamine (5-HT)1A and 5-HT4 receptor agonists on fast excitatory postsynaptic potentials (EPSPs) in… (More)
Is this relevant?
1991
1991
Peristalsis evoked by 5-HT and renzapride: evidence for putative 5-HT4 receptor activation.
The effect of 5-hydroxytryptamine and renzapride was studied on the peristaltic reflex elicited in vitro in the guinea-pig ileum… (More)
Is this relevant?
1991
1991
The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis.
Gastric emptying was measured in 9 diabetic patients with autonomic neuropathy (Group 1) and 8 normal controls (Group 2) on 4… (More)
Is this relevant?
1991
1991
Alpha 2-adrenergic model of gastroparesis: validation with renzapride, a stimulator of motility.
Motility-stimulating drugs can increase gastric antral and intestinal contractions but do not usually enhance emptying unless… (More)
Is this relevant?